RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss
Adel Ersek, Myoung Sook Kim, Caterina Suelzu, Isabelle Piec, Aerielle Matsangos, Elmar Nurmemmedov, Emma C. Bull, Tabitha Bartlett, Rachel Dunn, James R. Dick, Rena Lapidus, Danielle M. Copeman, Jonathan C. Y. Tang, Paul G. Crichton, Matthew G. Pontifex, William D. Fraser, Nicole J. Horwood, Antonin · 2026
Read RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss by Adel Ersek, Myoung Sook Kim, Caterina Suelzu, Isabelle Piec, Aerielle Matsangos, Elmar Nurmemmedov, Emma C. Bull, Tabitha Bartlett, Rachel Dunn, James R. Dick, Rena Lapidus, Danielle M. Copeman, Jonathan C. Y. Tang, Paul G. Crichton, Matthew G. Pontifex, William D. Fraser, Nicole J. Horwood, Antonin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13550584.txt.
Description
Adel Ersek and a large team test whether a cancer drug candidate that blocks the RUNX2 factor can also protect bone after menopause-type loss. Their paper appeared in two thousand twenty-six. Osteoporosis treatments carry safety limits and adherence problems. RUNX2 drives bone-building cells, making it a tempting but tricky target.
In mice lacking ovaries, the drug boosted bone formation and preserved spongy bone structure. Marrow and body fat also shrank under treatment. Cross-species studies showed the drug is absorbed orally and tolerated in the short term. Cell assays confirmed it engages RUNX2 directly despite quick clearance. The authors see a dual benefit: stronger skeleton plus better metabolic balance. They back further development for bone loss and other RUNX2-driven diseases. Human trials would be the next gate.
Catalog record
| CREATOR | Adel Ersek, Myoung Sook Kim, Caterina Suelzu, Isabelle Piec, Aerielle Matsangos, Elmar Nurmemmedov, Emma C. Bull, Tabitha Bartlett, Rachel Dunn, James R. Dick, Rena Lapidus, Danielle M. Copeman, Jonathan C. Y. Tang, Paul G. Crichton, Matthew G. Pontifex, William D. Fraser, Nicole J. Horwood, Antonin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |